FMR LLC

Position in TRVI — Trevi Therapeutics, Inc.

CIK 315066 BOSTON, MA

Position in TRVI

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$95,894,067

+$14,513,956 QoQ

Shares Held

8,038,061

+23.7% QoQ

Ownership

5.66%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

19 quarters on record

Voting authority Sole 99.9031856065785.ToString("F0")% Shared 0.ToString("F0")% None 0.09681439342149804.ToString("F0")%

Healthcare · as of Mar 31, 2026

FMR LLC holds $49,683,576,696 across 351 Biotechnology names. TRVI ranks #80 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	14,579,166	$4,823,808,652
2	ARGX	Argenx SE	4,991,034	$3,644,702,577
3	MRNA	Moderna, Inc.	45,672,024	$2,320,138,818
4	ROIV	Roivant Sciences Ltd.	77,981,253	$2,160,080,705
5	INSM	INSMED Inc	13,160,167	$2,151,950,504
6	IONS	Ionis Pharmaceuticals Inc	24,556,637	$1,843,957,869
7	RPRX	Royalty Pharma plc	25,152,242	$1,206,553,046
8	REGN	Regeneron Pharmaceuticals, Inc.	1,518,192	$1,173,015,865

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$95,894,067	8,038,061	+23.7%	Shares	Defined	2026-05-15
2025-12-31	$81,380,111	6,500,009	+97.0%	Shares	Defined	2026-02-17
2025-09-30	$30,194,001	3,299,891	+795.4%	Shares	Defined	2025-11-13
2025-06-30	$2,015,853	368,529	+6041.1%	Shares	Defined	2025-08-14
2025-03-31	$37,746	6,001	+37.6%	Shares	Defined	2025-05-12
2024-12-31	$17,963	4,360	+18.0%	Shares	Defined	2025-02-13
2024-09-30	$12,341	3,695	+2.5%	Shares	Defined	2024-11-13
2024-06-30	$10,739	3,604	+2.0%	Shares	Defined	2024-08-13
2024-03-31	$12,195	3,535	+0.7%	Shares	Defined	2024-05-13
2023-12-31	$4,704	3,511	+122.2%	Shares	Defined	2024-02-13
2023-09-30	$3,444	1,580	+78.3%	Shares	Defined	2023-11-13
2023-06-30	$2,117	886	-99.9%	Shares	Defined	2023-08-11
2022-09-30	$2,402,592	1,560,125	+1774.6%	Shares	Defined	2022-11-10
2022-06-30	$233,862	83,225	-85.6%	Shares	Defined	2022-08-12
2021-03-31	$1,562,315	576,500	0.0%	Shares	Defined	2021-05-14
2020-12-31	$1,395,130	576,500	-27.3%	Shares	Defined	2021-02-08
2020-09-30	$3,194,581	792,700	0.0%	Shares	Defined	2020-11-13
2020-06-30	$5,215,966	792,700	0.0%	Shares	Defined	2020-08-24
2020-03-31	$2,607,983	792,700	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.